HK Stock Market Move | SHANDONG XINHUA (00719) fell more than 3% after its performance results, with the net profit attributable to shareholders in the first three quarters dropping by 25.53% year-on-year.

10:34 27/10/2025

Shandong Xinhua Pharmaceutical Co., Ltd. (00719) fell more than 3% after its performance results, as of the time of publication, it fell by 3.17% to 7.03 Hong Kong dollars, with a trading volume of 31.1625 million Hong Kong dollars.

SHANDONG XINHUA (00719) fell more than 3% after its performance, dropping by 3.17% to HK$7.03 as of the time of publication, with a turnover of HK$31.1625 million. On the news front, on October 24, SHANDONG XINHUA released its performance for the nine months ending September 30, 2025. The operating income was RMB 6.763 billion, a year-on-year increase of 0.42%; the net profit attributable to shareholders of the listed company was RMB 2.56 billion, a year-on-year decrease of 25.53%; and the basic earnings per share were RMB 0.37.

HK Stock Market Move | MINTH GROUP (00425) rises nearly 10% in the afternoon, JP Morgan says the company's expansion into new markets will drive a revaluation of its valuation.

Guosen: The compliance of the second-generation refrigerant quota has been reduced, while the flexibility of the third-generation refrigerant quota adjustment has been increased.

HK Stock Market Move | GIANT BIOGENE (02367) fell more than 6% in the afternoon. The promotion of new medical and beauty products from approval to market still requires a certain amount of preparation time.

HK Stock Market Move | MINTH GROUP (00425) rises nearly 10% in the afternoon, JP Morgan says the company's expansion into new markets will drive a revaluation of its valuation.

Guosen: The compliance of the second-generation refrigerant quota has been reduced, while the flexibility of the third-generation refrigerant quota adjustment has been increased.